1. Home
  2. AMBO vs GTBP Comparison

AMBO vs GTBP Comparison

Compare AMBO & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

HOLD

Current Price

$2.41

Market Cap

6.5M

Sector

Real Estate

ML Signal

HOLD

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.31

Market Cap

8.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
GTBP
Founded
2000
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
8.8M
IPO Year
2010
2016

Fundamental Metrics

Financial Performance
Metric
AMBO
GTBP
Price
$2.41
$0.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
54.6K
681.2K
Earning Date
08-05-2025
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
337.04
3.75
EPS
0.01
N/A
Revenue
$9,469,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$325.68
N/A
Revenue Growth
0.82
N/A
52 Week Low
$1.47
$0.26
52 Week High
$6.75
$3.73

Technical Indicators

Market Signals
Indicator
AMBO
GTBP
Relative Strength Index (RSI) 49.23 39.12
Support Level $1.80 $0.26
Resistance Level $2.50 $0.48
Average True Range (ATR) 0.29 0.04
MACD -0.01 0.00
Stochastic Oscillator 51.32 33.65

Price Performance

Historical Comparison
AMBO
GTBP

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: